ArticleThoracic cancer2022

Serum immunogloblins might be useful predictors of immune-related adverse events after immune checkpoint inhibitor usage in lung cancer.

Manabu Yasuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.